1009729-55-8,
((3-(trifluoromethyl)phenyl)sulfonyl)methionine,
4-(methylsulfanyl)-2-[3-(trifluoromethyl)benzenesulfonamido]butanoic acid,
MFCD06409371,
4-Methylsulfanyl-2-(3-trifluoromethyl-benzenesulfonylamino)-butyric acid,
AC1Q4HDJ,
AC1MR05H,
CTK7B5829,
STL307365,
4-methylsulfanyl-2-[[3-(trifluoromethyl)phenyl]sulfonylamino]butanoic Acid,
AKOS000122576,
AKOS016055063,
MCULE-4142151428,
NE58879,
ST50134285,
EN300-04194,
N-{[3-(trifluoromethyl)phenyl]sulfonyl}methionine,
SR-01000112800,
SR-01000112800-1,
Z45637283,
F1408-0292,
4-methylthio-2-({[3-(trifluoromethyl)phenyl]sulfonyl}amino)butanoic acid,
CID3485177,
S-Methyl-N-[3-(trifluoromethyl)phenylsulfonyl]-DL-homocysteine,